Thrombophilic gene polymorphisms in puerperal cerebral veno-sinus thrombosis

Journal of the Neurological Sciences

Volumn 249, Issue 1, 2006, Pages 25-30

  Dindagur, Nagaraja ^a   Kruthika Vinod, T P ^a   Christopher, Rita ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Factor V Leiden; MTHFR C677T polymorphism; Prothrombin G20210A; Puerperal cerebral veno sinus thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; OCCLUSIVE CEREBROVASCULAR DISEASE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PUERPERAL CEREBRAL VENO SINUS THROMBOSIS; PUERPERIUM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; THROMBOPHILIA;

ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS; BLOOD PROTEINS; DNA MUTATIONAL ANALYSIS; FACTOR V; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; INDIA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROTHROMBIN; PUERPERAL DISORDERS; SINUS THROMBOSIS, INTRACRANIAL;

EID: 33750504417     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.05.061     Document Type: Article

References (47)

1. Nagaraja D. Brain veins and their diseases. In: Toole J.F. (Ed). Cerebrovascular disorders (2004), Lippincott Williams and Wilkins, New York 481-506
2. Srinivasan K. Cerebral venous and arterial thrombosis in pregnancy and puerperium. A study of 135 patients. Angiology 34 (1983) 731-746
3. Bansal B.C., Gupta R.R., and Prakash C. Stroke during pregnancy and puerperium in young females below the age of 40 years as a result of cerebral venous/venous sinus thrombosis. Jpn Heart J 21 (1980) 171-183
4. Simolke G.A., Cox S.M., and Cunningham F.G. Cerebrovascular accidents complicating pregnancy and the puerperium. Obstet Gynecol 78 (1991) 37-42
5. Mas J.L., and Lamy C. Stroke in pregnancy and the puerperium. J Neurol 245 (1998) 305-313
6. Hertzberg M.S. Genetic testing for thrombophilia mutations. Semin Thromb Hemost 31 (2005) 33-38
7. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
8. Bertina R.M., Koeleman B.P., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
9. Poort S.R., Rosendaal F.R., Reitsma P.H., and Bertina R.M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88 (1996) 3698-3703
10. Zivelin A., Rosenberg N., Faier S., Kornbrot N., Peretz H., Mannhalter C., et al. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 92 (1998) 1119-1124
11. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylene tetrahydrofolate reductase gene. Nat Genet 10 (1995) 111-113
12. Seligsohn U., and Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 344 (2001) 1222-1231
13. Zivelin A., Griffin J.H., Xu X., Pabinger I., Samama M., Conard J., et al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 89 (1997) 397-402
14. Gupta N., Khan F., Tripathi M., Singh V.P., Tewari S., Ramesh V., et al. Absence of factor V Leiden (G1691A) mutation, FII G20210A allele in coronary artery disease in north India. Indian J Med Sci 57 (2003) 535-542
15. Pawar A.R., Shetty S., Ghosh K., and Mohanty D. How old is factor V Leiden mutation?. Thromb Hemost 86 (2001) 1591-1592
16. Gerhardt A., Scharf R.E., Beckmann M.W., Struve S., Bender H.F., Pillny M., et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 342 (2000) 374-380
17. Tormene D., Simioni P., Prandoni P., Luni S., Zerbinati P., Sartor D., et al. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women. Haematologica 86 (2001) 1305-1309
18. Zuber M., Toulon P., Mamet L., and Mas J.L. Factor V Leiden mutation in cerebral venous thrombosis. Stroke 27 (1996) 1721-1723
19. Ludemann P., Nabavi D.G., Junker R., Wolff E., Papke K., Buchner H., et al. Factor V Leiden mutation is a risk factor for cerebral vein thrombosis: a case-control study of 55 patients. Stroke 29 (1998) 2507-2510
20. Weih M., Vetter B., Ziemer S., Mehraein S., Valdueza J.M., Koscielny J., et al. Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis. J Neurol 245 (1998) 149-152
21. Martinelli I., Landi G., Merati G., Cella R., Tosetto A., and Mannucci P.M. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost 75 (1996) 393-394
22. Yanqing H., Fangping C., Qinzhi X., Zaifu J., Guangping W., Xiaoxia Z., et al. No association between thrombosis and factor V gene polymorphisms in Chinese Han population. Thromb Haemost 89 (2003) 446-451
23. Kumar S.I., Kumar A., Srivastava S., Saraswat V.A., and Aggarwal R. Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a case-control study. Indian J Gastroenterol 24 (2005) 211-215
24. Ghosh K., Shetty S., Madkaikar M., Pawar A., Nair S., Khare A., et al. Venous thromboembolism in young patients from western India: a study. Clin Appl Thromb Hemost 7 (2001) 158-165
25. Rodrigues C.A., Rocha L.K., Morelli V.M., Franco R.F., and Lourenco D.M. Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients. J Thromb Haemost 2 (2004) 1211-1212
26. Garewal G., Das R., Varma S., Chawla Y., and Prabhakar S. Heterogeneous distribution of factor V Leiden in patients from north India with venous thromboembolism. J Thromb Haemost 1 (2003) 1329-1330
27. Rosendaal F.R., Doggen C.J., and Zivelin A. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 79 (1998) 706-708
28. Margaglione M., D'Andrea G., Colaizzo D., Cappucci G., del Popolo A., Brancaccio V., et al. Coexistence of factor V Leiden and factor II A20210 mutation and recurrent venous thromboembolism. Thromb Haemost 82 (1999) 1583-1587
29. Hillier C.E., Collins P.W., Bowen D.J., Bowley S., and Wiles C.M. Inherited prothrombotic risk factors and cerebral venous thrombosis. QJM 91 (1998) 677-680
30. Madonna P., de Stefano A., Coppola A., Albisinni R., and Cerbone A.M. G20210A PRTH gene mutation and other thrombophilic polymorphisms in cerebral venous thrombosis. Stroke 31 (2000) 1787-1788
31. Martinelli I., Sacchi E., Landi G., Taioli E., Duca F., and Mannucci P.M. High risk of cerebral-vein thrombosis in carriers of a prothrombin gene mutation and in users of oral contraceptives. N Engl J Med 338 (1998) 1793-1797
32. Gadelha T., Andre C., Juca A.A., and Nucci M. Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis. Cerebrovasc Dis 19 (2005) 49-52
33. Reuner K.H., Ruf A., Grau A., Rickmann H., Stolz E., Juttler E., et al. Prothrombin gene G20210-A transition is a risk factor for cerebral venous thrombosis. Stroke 29 (1998) 1765-1769
34. Solz E., Kemkes-Matthes B., Potzsch B., Hahn M., Kraus J., Wirbartz A., et al. Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis. Acta Neurol Scand 102 (2000) 31-36
35. Lichy C., Dong-Si T., Reuner K., Genius J., Rickmann H., Hampe T., et al. Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems. J Neurol 253 (2006) 316-320
36. Weih M., Junge-Hulsing J., Mehraein S., Ziemer S., and Einhaupl K.M. Hereditary thrombophilia with ischemic stroke and sinus thrombosis. Diagnosis, therapy and meta-analysis. Nervenarzt 71 (2000) 936-945
37. Dentali F., Crowther M., and Dentali W.A. Thrombophilic abnormalities, oral contraceptives and risk of cerebral vein thrombosis: a meta-analysis. Blood 107 (2006) 2766-2773
38. Koshy A., and Jeyakumari M. Prothrombin G20210A gene variant is not associated with idiopathic portal vein thrombosis in an area endemic for portal vein thrombosis. Ann Hematol 85 (2006) 126-128
39. Garewal G., Das R., Ahluwalia J., Mittal N., and Varma S. Prothrombin 20210A is not prevalent in north India. J Thromb Haemost 1 (2003) 2253-2254
40. Rees D.C., Chapman N.H., Webster M.T., Guerreiro J.F., Rochette J., and Clegg J.B. Born to clot: the European burden. Br J Haematol 105 (1999) 564-566
41. Ma J., Stampfer M.J., Hennekens C.H., Frosst P., Selhub J., Horsford J., et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 94 (1996) 2410-2416
42. Verhoef P., Kok F.J., Kluijtmans L.A., Blom H.J., Refsum H., Ueland P.M., et al. The 677C→T mutation in the methylenetetra hydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 132 (1997) 105-113
43. Den Heijer M., Lewington S., and Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 3 (2005) 292-299
44. Chambers J.C., Ireland H., Thompson E., Reilly P., Obeid O.A., Refsum H., et al. Methylenetetrahydrofolate reductase 677 C→T mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol 20 (2000) 2448-2452
45. Angeline T., Bentley H.A., Hawk A.B., Manners R.J., Mokashi H.A., Jeyaraj N., et al. Prevalence of the factor V G1691A and the factor II/prothrombin G20210A gene polymorphisms among Tamilians. Exp Mol Pathol 79 (2005) 9-13
46. Martinelli I., Battaglioli T., Pedotti P., Cattaneo M., and Mannucci P.M. Hyperhomocysteinemia in cerebral vein thrombosis. Blood 102 (2003) 1363-1366
47. Cantu C., Alonso E., Jara A., Martinez L., Rios C., Fernandez Mde L., et al. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 35 (2004) 1790-1794